{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:08:22Z","timestamp":1761898102985,"version":"3.41.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41417-025-00900-0","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T06:53:38Z","timestamp":1744008818000},"page":"633-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of LncRNA-MANCR induced by HIF-1\u03b1 drive the malignant progression of pancreatic cancer by targeting miRNA-494\/SIRT1 signaling axis under hypoxic conditions"],"prefix":"10.1038","volume":"32","author":[{"given":"Yan","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-987X","authenticated-orcid":false,"given":"Xiaoxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-4336","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"900_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"900_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"900_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. Gastroenterology. 2022;163:386\u2013402.e1.","journal-title":"Gastroenterology"},{"key":"900_CR4","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.2147\/IJN.S413496","volume":"18","author":"H Duan","year":"2023","unstructured":"Duan H, Li L, He S. Advances and Prospects in the Treatment of Pancreatic Cancer. Int J Nanomed. 2023;18:3973\u201388.","journal-title":"Int J Nanomed"},{"key":"900_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215751","volume":"548","author":"Z He","year":"2022","unstructured":"He Z, Wang J, Zhu C, Xu J, Chen P, Jiang X, et al. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Lett. 2022;548:215751.","journal-title":"Cancer Lett"},{"key":"900_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01647-0","volume":"21","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu X, Wang Y, Lai S, Wang Z, Yang Y, et al. The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol Cancer. 2022;21:174.","journal-title":"Mol Cancer"},{"key":"900_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-022-02516-w","volume":"41","author":"DD Cave","year":"2022","unstructured":"Cave DD, Buonaiuto S, Sainz B Jr, Fantuz M, Mangini M, Carrer A, et al. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. J Exp Clin Cancer Res. 2022;41:315.","journal-title":"J Exp Clin Cancer Res"},{"key":"900_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","volume":"15","author":"A Fatica","year":"2014","unstructured":"Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7\u201321.","journal-title":"Nat Rev Genet"},{"key":"900_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05172-2","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, He Z, Liu X, Xu J, Jiang X, Quan G, et al. LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2. Cell Death Dis. 2022;13:718.","journal-title":"Cell Death Dis"},{"key":"900_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13046-022-02491-2","volume":"41","author":"M Zhou","year":"2022","unstructured":"Zhou M, Pan S, Qin T, Zhao C, Yin T, Gao Y, et al. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect \u03b2-catenin from degradation. J Exp Clin Cancer Res. 2022;41:288.","journal-title":"J Exp Clin Cancer Res"},{"key":"900_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/MPA.0000000000002164","volume":"51","author":"F Jiang","year":"2022","unstructured":"Jiang F, Li S, Wang X, Deng Y, Peng S. DPP10-AS1-mediated downregulation of MicroRNA-324-3p Is conducive to the malignancy of pancreatic cancer by enhancing CLDN3 Expression. Pancreas. 2022;51:1201\u201310.","journal-title":"Pancreas"},{"key":"900_CR12","doi-asserted-by":"publisher","first-page":"18016","DOI":"10.1074\/jbc.RA118.004006","volume":"293","author":"M Terashima","year":"2018","unstructured":"Terashima M, Ishimura A, Wanna-Udom S, Suzuki T. MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells. J Biol Chem. 2018;293:18016\u201330.","journal-title":"J Biol Chem"},{"key":"900_CR13","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","volume":"81","author":"F Xu","year":"2021","unstructured":"Xu F, Huang M, Chen Q, Niu Y, Hu Y, Hu P, et al. LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1a pathway. Cancer Res. 2021;81:5678\u201391.","journal-title":"Cancer Res"},{"key":"900_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-022-01272-w","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shi M, He X, Cao Y, Liu P, Li F, et al. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2022;15:52.","journal-title":"J Hematol Oncol"},{"key":"900_CR15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/1541-7786.MCR-22-0024","volume":"20","author":"X Qiu","year":"2022","unstructured":"Qiu X, Shi Q, Zhang X, Shi X, Jiang H, Qin S. LncRNA A2M-AS1 promotes ferroptosis in pancreatic cancer via interacting with PCBP3. Mol Cancer Res. 2022;20:1636\u201345.","journal-title":"Mol Cancer Res"},{"key":"900_CR16","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.18632\/oncotarget.6830","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Deng SJ, Zhu S, Jin Y, Cui SP, Chen JY, et al. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923\/KRAS pathway. Oncotarget. 2016;7:6000\u201314.","journal-title":"Oncotarget"},{"key":"900_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.761979","volume":"11","author":"Y Jin","year":"2021","unstructured":"Jin Y, Zhang Z, Yu Q, Zeng Z, Song H, Huang X, et al. Positive reciprocal feedback of lncRNA ZEB1-AS1 and HIF-1\u03b1 contributes to hypoxia-promoted tumorigenesis and metastasis of pancreatic cancer. Front Oncol. 2021;11:761979.","journal-title":"Front Oncol"},{"key":"900_CR18","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79:4557\u201366.","journal-title":"Cancer Res"},{"key":"900_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-3173","volume":"21","author":"HY Jung","year":"2015","unstructured":"Jung HY, Fattet L, Yang J. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clin Cancer Res. 2015;21:962\u20138.","journal-title":"Clin Cancer Res"},{"key":"900_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18:157.","journal-title":"Mol Cancer"},{"key":"900_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, Yang G, Zhou W, Qiu J, Chen G, Luo W, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14:14.","journal-title":"J Hematol Oncol"},{"key":"900_CR22","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.7150\/thno.30988","volume":"9","author":"M Liu","year":"2019","unstructured":"Liu M, Zhong J, Zeng Z, Huang K, Ye Z, Deng S, et al. Hypoxia-induced feedback of HIF-1a and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Theranostics. 2019;9:4795\u2013810.","journal-title":"Theranostics"},{"key":"900_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41388-017-0082-2","volume":"37","author":"Y Niu","year":"2018","unstructured":"Niu Y, Jin Y, Deng SC, Deng SJ, Zhu S, Liu Y, et al. MiRNA-646-mediated reciprocal repression between HIF-1a and MIIP contributes to tumorigenesis of pancreatic cancer. Oncogene. 2018;37:1743\u201358.","journal-title":"Oncogene"},{"key":"900_CR24","doi-asserted-by":"publisher","first-page":"39661","DOI":"10.18632\/oncotarget.5350","volume":"6","author":"S Deng","year":"2015","unstructured":"Deng S, Li X, Niu Y, Zhu S, Jin Y, Deng S, et al. MiR-652 inhibits acidic microenvironment induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Oncotarget. 2015;6:39661\u201375.","journal-title":"Oncotarget"},{"key":"900_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.189","volume":"8","author":"S Zhu","year":"2017","unstructured":"Zhu S, Zhou HY, Deng SC, Deng SJ, He C, Li X, et al. ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+\/RhoA pathway. Cell Death Dis. 2017;8: e2806 https:\/\/doi.org\/10.1038\/cddis.2017.189.","journal-title":"Cell Death Dis"},{"key":"900_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u201326.","journal-title":"Trends Cell Biol"},{"key":"900_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40:e108647.","journal-title":"EMBO J"},{"key":"900_CR28","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1002\/jcp.26302","volume":"233","author":"J Choupani","year":"2018","unstructured":"Choupani J, Mansoori Derakhshan S, Bayat S, Alivand MR, Shekari Khaniani M. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. J Cell Physiol. 2018;233:4443\u201357.","journal-title":"J Cell Physiol"},{"key":"900_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3031459","volume":"2016","author":"R Palmirotta","year":"2016","unstructured":"Palmirotta R, Cives M, Della-Morte D, Capuani B, Lauro D, Guadagni F, et al. Sirtuins and cancer: role in the epithelial-mesenchymal transition. Oxid Med Cell Longev. 2016;2016. 3031459.","journal-title":"Oxid Med Cell Longev"},{"key":"900_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2014.08.007","volume":"355","author":"S Deng","year":"2014","unstructured":"Deng S, Zhu S, Wang B, Li X, Liu Y, Qin Q, et al. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett. 2014;355:184\u201391.","journal-title":"Cancer Lett"},{"key":"900_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01638-1","volume":"21","author":"L Zhou","year":"2022","unstructured":"Zhou L, Jiang J, Huang Z, Jin P, Peng L, Luo M, et al. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt\/\u03b2-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA. Mol Cancer. 2022;21:168.","journal-title":"Mol Cancer"},{"key":"900_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04536-y","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Yang J, Ni R, Chen J, Zhou Y, Song H, et al. Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt\/\u03b2-catenin signaling in breast cancer. Cell Death Dis. 2022;13:95.","journal-title":"Cell Death Dis"},{"key":"900_CR33","doi-asserted-by":"publisher","first-page":"D46","DOI":"10.1093\/nar\/gkac1067","volume":"51","author":"J Huang","year":"2023","unstructured":"Huang J, Zheng W, Zhang P, Lin Q, Chen Z, Xuan J, et al. ChIPBase v3.0: the encyclopedia of transcriptional regulations of non-coding RNAs and protein-coding genes. Nucleic Acids Res. 2023;51:D46\u2013D56.","journal-title":"Nucleic Acids Res"},{"key":"900_CR34","first-page":"6801","volume":"18","author":"L Yao","year":"2019","unstructured":"Yao L, Yan J, Gan L, Huang S, Cheng F, Fang N. Upregulation of MANCR predicts poor survival in patients with gastric cancer. Oncol Lett. 2019;18:6801\u20136.","journal-title":"Oncol Lett"},{"key":"900_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2020.03.043","volume":"526","author":"M Nagasawa","year":"2020","unstructured":"Nagasawa M, Tomimatsu K, Terada K, Kondo K, Miyazaki K, Miyazaki M, et al. Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer. Biochem Biophys Res Commun. 2020;526:128\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"900_CR36","first-page":"1250","volume":"68","author":"F Tahmouresi","year":"2021","unstructured":"Tahmouresi F, Razmara E, Pakravan K, Mossahebi-Mohammadi M, Rouhollah F, Montazeri M, et al. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma. Biotechnol Appl Biochem. 2021;68:1250\u20136.","journal-title":"Biotechnol Appl Biochem"},{"key":"900_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12890-021-01635-y","volume":"21","author":"C Liu","year":"2021","unstructured":"Liu C, Li H, Li X, Zhao X, Zhang X. LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma. BMC Pulm Med. 2021;21:272.","journal-title":"BMC Pulm Med"},{"key":"900_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-3-030-65768-0_13","volume":"1311","author":"JG Jung","year":"2021","unstructured":"Jung JG, Le A. Metabolism of immune cells in the tumor microenvironment. Adv Exp Med Biol. 2021;1311:173\u201385.","journal-title":"Adv Exp Med Biol"},{"key":"900_CR39","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.3390\/molecules25204831","volume":"25","author":"J Li","year":"2020","unstructured":"Li J, Eu JQ, Kong LR, Wang L, Lim YC, Goh BC, et al. Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy. Molecules. 2020;25:4831.","journal-title":"Molecules"},{"key":"900_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41571-021-00539-4","volume":"18","author":"DC Singleton","year":"2021","unstructured":"Singleton DC, Macann A, Wilson WR. Therapeutic targeting of the hypoxic tumour microenvironment. Nat Rev Clin Oncol. 2021;18:751\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"900_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01288-1","volume":"20","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, et al. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021;20:7.","journal-title":"Mol Cancer"},{"key":"900_CR42","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s00018-019-03444-3","volume":"77","author":"Z Tan","year":"2020","unstructured":"Tan Z, Xu J, Zhang B, Shi S, Yu X, Liang C. Hypoxia: a barricade to conquer the pancreatic cancer. Cell Mol Life Sci. 2020;77:3077\u201383.","journal-title":"Cell Mol Life Sci"},{"key":"900_CR43","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.7150\/thno.43839","volume":"10","author":"Q Hua","year":"2020","unstructured":"Hua Q, Mi B, Xu F, Wen J, Zhao L, Liu J, et al. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2\/HIF-1a axis. Theranostics. 2020;10:4762\u201378.","journal-title":"Theranostics"},{"key":"900_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485\u201390.","journal-title":"Nature"},{"key":"900_CR45","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00894-011-1150-0","volume":"18","author":"P Sokkar","year":"2012","unstructured":"Sokkar P, Sathis V, Ramachandran M. Computational modeling on the recognition of the HRE motif by HIF-1: molecular docking and molecular dynamics studies. J Mol Model. 2012;18:1691\u2013700.","journal-title":"J Mol Model"},{"key":"900_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271\u20135.","journal-title":"Nature"},{"key":"900_CR47","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0092-8674(02)01085-1","volume":"111","author":"JW Jeong","year":"2002","unstructured":"Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002;111:709\u201320.","journal-title":"Cell"},{"key":"900_CR48","doi-asserted-by":"crossref","unstructured":"Kim SH, Jeong JW, Park JA, Lee JW, Seo JH, Jung BK, et al. Regulation of the HIF-1alpha stability by histone deacetylases. Oncol Rep. 2007;17:647\u201351.","DOI":"10.3892\/or.17.3.647"},{"key":"900_CR49","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41388-023-02592-y","volume":"42","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Luo Z, Gong Y, Fu Y, Luo Y. NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling. Oncogene. 2023;42:808\u201324.","journal-title":"Oncogene"},{"key":"900_CR50","doi-asserted-by":"publisher","first-page":"e45331","DOI":"10.1371\/journal.pone.0045331","volume":"7","author":"M Xie","year":"2012","unstructured":"Xie M, Liu M, He CS. SIRT1 regulates endothelial Notch signaling in lung cancer. PLoS One. 2012;7:e45331.","journal-title":"PLoS One"},{"key":"900_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/carcin\/bgac093","volume":"45","author":"D Yang","year":"2024","unstructured":"Yang D, Zhang P, Yang Z, Hou G, Yang Z. miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1. Carcinogenesis. 2024;45:463\u201374.","journal-title":"Carcinogenesis"},{"key":"900_CR52","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41388-020-1298-0","volume":"39","author":"L Yu","year":"2020","unstructured":"Yu L, Dong L, Li H, Liu Z, Luo Z, Duan G, et al. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis. Oncogene. 2020;39:4450\u201364.","journal-title":"Oncogene"},{"key":"900_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/or.2022.8354","volume":"48","author":"J Huang","year":"2022","unstructured":"Huang J, Zhang F, Hu G, Pan Y, Sun W, Jiang L, et al. SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression. Oncol Rep. 2022;48:143.","journal-title":"Oncol Rep."},{"key":"900_CR54","doi-asserted-by":"publisher","first-page":"10227","DOI":"10.3390\/ijms231810227","volume":"23","author":"S Dilmac","year":"2022","unstructured":"Dilmac S, Kuscu N, Caner A, Yildirim S, Yoldas B, Farooqi AA, et al. SIRT1\/FOXO signaling pathway in breast cancer progression and metastasis. Int J Mol Sci. 2022;23:10227.","journal-title":"Int J Mol Sci"},{"key":"900_CR55","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1038\/s41418-021-00821-z","volume":"28","author":"S Leng","year":"2021","unstructured":"Leng S, Huang W, Chen Y, Yang Y, Feng D, Liu W, et al. SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. Cell Death Differ. 2021;28:3329\u201343.","journal-title":"Cell Death Differ"},{"key":"900_CR56","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.molcel.2010.05.023","volume":"38","author":"JH Lim","year":"2010","unstructured":"Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010;38:864\u201378.","journal-title":"Mol Cell"},{"key":"900_CR57","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbrc.2015.04.119","volume":"462","author":"HY Joo","year":"2015","unstructured":"Joo HY, Yun M, Jeong J, Park ER, Shin HJ, Woo SR, et al. SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1a (HIF-1a) via direct interactions during hypoxia. Biochem Biophys Res Commun. 2015;462:294\u2013300.","journal-title":"Biochem Biophys Res Commun"},{"key":"900_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01539-3","volume":"21","author":"ST Xue","year":"2022","unstructured":"Xue ST, Zheng B, Cao SQ, Ding JC, Hu GS, Liu W, et al. Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p\/PAK6 axis. Mol Cancer. 2022;21:69.","journal-title":"Mol Cancer"},{"key":"900_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00304-1","volume":"8","author":"YX Song","year":"2017","unstructured":"Song YX, Sun JX, Zhao JH, Yang YC, Shi JX, Wu ZH, et al. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA-mediated miRNA evasion. Nat Commun. 2017;8:289.","journal-title":"Nat Commun"},{"key":"900_CR60","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/gt.2015.39","volume":"22","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li X, Zhu S, Zhang JG, Yang M, Qin Q, et al. Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther. 2015;22:729\u201338.","journal-title":"Gene Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00900-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T22:02:25Z","timestamp":1750629745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00900-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00900-0","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"type":"print","value":"0929-1903"},{"type":"electronic","value":"1476-5500"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that may have influenced the work reported in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was conducted in accordance with the relevant guidelines and regulations that govern the ethical conduct of research in this field. The human patient consent forms and protocols for this study were approved by the Wannan Medical College Ethics Committee (No: Wannan Medical College IRB2020011), and written informed consent was obtained from all participants prior to their inclusion in the study. The ethical policies and procedures for animal experiments were approved by the Animal Ethics Committee of the Academic Medical Centre at Wannan Medical College (Wuhu, China) (No: LLSC-2020-081). All animal care and experimental procedures adhered to the guidelines outlined in the Guide for the Care and Use of Laboratory Animals (2011). It is also noteworthy that no identifiable images or other personal data of participants were used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}